Regulation of K+ current in human airway epithelial cells by exogenous and autocrine adenosine

Artur J. Szkotak1, Amy M. L. Ng1, Jolanta Sawicka1, Stephen A. Baldwin2, S. F. Paul Man1, Carol E. Cass3, James D. Young1, and Marek Duszyk1

Membrane Transport Research Group, Departments of 1 Physiology and 3 Oncology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7; and 2 School of Biochemistry and Molecular Biology, University of Leeds, Leeds, LS2 9JT, United Kingdom


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The regulatory actions of adenosine on ion channel function are mediated by four distinct membrane receptors. The concentration of adenosine in the vicinity of these receptors is controlled, in part, by inwardly directed nucleoside transport. The purpose of this study was to characterize the effects of adenosine on ion channels in A549 cells and the role of nucleoside transporters in this regulation. Ion replacement and pharmacological studies showed that adenosine and an inhibitor of human equilibrative nucleoside transporter (hENT)-1, nitrobenzylthioinosine, activated K+ channels, most likely Ca2+-dependent intermediate-conductance K+ (IK) channels. A1 but not A2 receptor antagonists blocked the effects of adenosine. RT-PCR studies showed that A549 cells expressed mRNA for IK-1 channels as well as A1, A2A, and A2B but not A3 receptors. Similarly, mRNA for equilibrative (hENT1 and hENT2) but not concentrative (hCNT1, hCNT2, and hCNT3) nucleoside transporters was detected, a result confirmed in functional uptake studies. These studies showed that adenosine controls the function of K+ channels in A549 cells and that hENTs play a crucial role in this process.

A549 cells; nitrobenzylthioinosine; human concentrative nucleoside transporter; human equilibrative nucleoside transporter; calcium-dependent intermediate-conductance potassium channels


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

THE PURINE NUCLEOSIDE ADENOSINE is an important mediator of many physiological functions, including transepithelial electrolyte secretion in human airways. Adenosine mediates its effects through the activation of high-affinity receptors, A1 and A2A, that are physiologically relevant and low-affinity receptors, A2B and A3, that could play a crucial role under inflammatory conditions (34). Stimulation of adenosine receptors activates anion conduction via both cystic fibrosis transmembrane conductance regulator (CFTR)-dependent and -independent pathways (11, 26, 39), although the underlying mechanisms are not fully understood.

The magnitude of the effect of adenosine on ion transport is related to its concentration in the vicinity of its cell surface receptors. In healthy subjects the average adenosine concentration in airway surface liquid is ~60 µM, whereas in patients with asthma it is ~200 µM (14). The increased adenosine concentration in asthmatic patients raises two important questions: What is the source of adenosine and how are its levels controlled? One factor that is believed to control adenosine concentrations is the balance between the activities of enzymes that catalyze its synthesis and those that catalyze its metabolism. Adenosine is produced by the action of membrane-bound 5'-nucleotidase on extracellular AMP, which is itself produced by the action of nonspecific (alkaline or acidic) phosphatases on ADP and ATP (35). Conversely, the metabolism of adenosine is mediated by the action of either adenosine kinase or adenosine deaminase, resulting in the conversion of adenosine to AMP or inosine, respectively (35). Because the majority of adenosine synthesis occurs extracellularly whereas most of its metabolism occurs intracellularly, inwardly directed transport of adenosine across the plasma membrane is also an important determinant of its extracellular concentration (8).

Because adenosine and other nucleosides are relatively hydrophilic, their uptake and release from cells depend on specialized nucleoside transporter proteins present in the plasma membrane (8). These are members of the concentrative (Na+ dependent) nucleoside transporter (CNT) and equilibrative (Na+ independent) nucleoside transporter (ENT) families (1, 7, 46). Molecular cloning studies in humans and rodents have identified three distinct members of the concentrative family (CNT1, CNT2, and CNT3) and two members of the equilibrative family (ENT1 and ENT2). Human (h)CNT1 and hCNT2 both transport uridine and certain uridine analogs but are otherwise selective for either pyrimidine (hCNT1) or purine (hCNT2) nucleosides, except for modest transport of adenosine by hCNT1 (37, 38, 41). In contrast, hCNT3 transports both purine and pyrimidine nucleosides (36). hENT1 and hENT2 also transport both purine and pyrimidine nucleosides and are distinguished functionally by a difference in sensitivity to inhibition by nitrobenzylthioinosine (NBTI), hENT2 being NBTI insensitive (12, 18, 19). They also differ in sensitivity to inhibition by the coronary vasodilators dipyridamole, dilazep, and draflazine (hENT1 > hENT2) and in the ability of hENT2 to transport nucleobases as well as nucleosides.

The concentrative (inwardly directed) nucleoside transporters of rodents and humans are expressed in specialized cells such as intestinal and renal epithelia, liver, choroid plexus, splenocytes, macrophages, and leukemic cells (1, 7, 46). The equilibrative (bidirectional) nucleoside transporters have generally lower substrate affinities than the concentrative transporters and occur in most, possibly all, human and rodent cell types. Although the role of nucleoside transport in the control of transepithelial anion secretion is unknown, it has been recently suggested that CNT2 could play an important role in the regulation of Na+ reabsorption in cultured rat epididymal epithelium (28).

The aim of the present study was to characterize the role of adenosine receptors and transporters in the regulation of ion transport in human airway epithelial cell line A549. These cells exhibit metabolic and transport properties consistent with type II pneumocytes and, because they do not express CFTR (16), constitute a convenient model for studying CFTR-independent regulation of ion transport by adenosine. Our data show that regulation of adenosine receptor function by hENTs controls ion transport in A549 cells.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell culture. A549 cells were obtained from the American Type Culture Collection (Rockville, MD) and grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 50 µg/ml gentamicin sulfate, 60 µg/ml penicillin G, and 100 µg/ml streptomycin. Cells were maintained in T25 tissue-culture flasks (Costar, Cambridge, MA) at 37°C in a humidified atmosphere of 5% CO2 in air. Confluent cell layers were passaged using saline solution containing 0.05% trypsin and 0.02% EDTA. For adenosine transport experiments, cells were seeded at a density of 106 cells/cm2 onto Costar Snapwell inserts (0.45-µm pore size, 1-cm2 surface area) coated with type VI human placental collagen (Sigma, St. Louis, MO). For the first 6 days, cells were grown submerged in culture medium that was changed every 2-3 days. Subsequently, air interface culturing was used, in which the medium was added only to the basolateral side of the inserts. For whole cell patch-clamp studies, cells were seeded onto 35-mm plates (Becton Dickinson, Franklin Lakes, NJ) at a density of 1.5 × 103 cells/cm2 at least 4 h before experiments.

Whole cell patch-clamp recordings. Pipette electrodes were made from thin-walled borosilicate glass (A-M Systems, Everett, WA) with a two-stage vertical puller (Nirashige). Electrode tips were fire polished to a final resistance of 3-6 MOmega immediately before experiments. The composition of pipette and bath solutions is given in Table 1. Cultured cells were rinsed three times in bath solution immediately before being mounted into a holder fixed to the stage of an Olympus IMT-2 inverted research microscope (Lake Success, NY). The holder maintained the bath solution at 37°C by means of a heat-exchange perfusion system. After the pipette had been immersed in the bath solution, offset potentials were compensated before a gigaohm seal was formed. Once sealed, the whole cell configuration was obtained mechanically, by suction, and the cell was immediately clamped to -40 mV. Currents were recorded at 1-min intervals with an Axopatch 200A amplifier and Clampex 8.0 software, both from Axon Instruments (Foster City, CA), in response to the voltage protocol shown in Fig. 1C. All currents were reported with reference to the ground electrode in the bath. The access resistance of the patch and cell capacitance were measured directly by the compensation circuitry of the patch-clamp amplifier and by Clampex 8.0 software. The whole cell capacitance in these experiments, expressed as mean ± SD, was 27 ± 6 pF (n = 125), and only seals with a series resistance of <20 MOmega were used. All data were analyzed by Clampfit 8.0 (Axon Instruments), Microsoft Excel 97 (Seattle, WA), and Micrococal Origin 5.0 (Northampton, MA) software. Traces were first normalized to 1 pF to remove variability due to cell size. The current-voltage relationship was obtained from the mean current during the central 140 ms of the recording. The whole cell current chord conductance (gamma ) was computed from the equation I = gamma (V - Erev), where I is the whole cell current, V is the applied voltage, and Erev is the whole cell current reversal potential. Calculations of chord conductance were performed at V = 40 mV.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Patch-clamp solutions



View larger version (34K):
[in this window]
[in a new window]
 
Fig. 1.   Stimulatory effect of adenosine and nitrobenzylthioinosine (NBTI) on whole cell current. A: representative traces showing the activation of whole cell current by 100 µM adenosine (Ado, n = 8). B: representative traces showing the activation of whole cell current by 10 µM NBTI (n = 15). C: voltage protocol used for all experiments performed in this study. D: summary of experiments done with adenosine and NBTI showing the change in membrane chord conductance on addition of nucleoside or nucleoside transport inhibitor. All values are means ± SE of chord conductance density. *Statistical significance (P < 0.01).

Data are presented as means ± SE; n refers to the number of experiments. The paired Student's t-test was used to compare the means of two groups. Statistically significant differences among the means of multiple groups were determined by one-way analysis of variance (ANOVA) with the Tukey-Kramer post test with the use of GraphPad Instat 3.05 software (San Diego, CA). A value of P <0.05 was considered statistically significant.

RT-PCR. Total RNA was isolated from 2 × 106 cells using the Qiagen RNeasy kit. The average amount of RNA obtained from 2 × 106 cells was ~400 ng. One-fourth of the RNA was reverse transcribed with the use of Superscript II reverse transcriptase (GIBCO BRL) and either oligo(dT) or random hexamers (50 A260 units; Boehringer Mannheim) as primers. Thereafter, PCR was performed in 20-µl reactions with the primer pairs (25 µM) described in Table 2. In addition to the primers designed to amplify sequences of interest, reactions with glyceraldehyde-3-phosphate dehydrogenase (GAPDH)- specific primers were run in all rounds of PCR reactions to serve as internal positive controls. One-tenth of the cDNA was used in PCR experiments, and amplification proceeded by annealing for 30 s at the temperatures indicated in Table 2, followed by an elongation step at 72°C for 1 min. Sequences were amplified over 30 or 38 cycles, and PCR products with the expected sizes, shown in Table 2, were resolved on 1.5% agarose gels. All RT-PCR products were sequenced in one [adenosine receptors and Ca2+-dependent intermediate-conductance K+ (IK)-1 channels] or both (nucleoside transporters) directions by Taq dideoxyterminator cycle sequencing with an automated DNA sequencer (model 373A, Applied Biosystems, Foster City, CA).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Summary of RT-PCR primers and conditions

Nucleoside transport. Experiments were carried out at 20°C in HEPES-buffered Ringer's solution (HPBR) containing (in mM) 135 NaCl, 5.0 KCl, 3.33 NaH2PO4, 1.0 CaCl2, 1.0 MgCl2, 10 glucose, and 5.0 HEPES (pH = 7.4 at 20°C) or in Na+-free HPBR containing (in mM) 140 N-methyl-D-glucamine, 5.0 KH2PO4, 1.0 CaCl2, 1.0 MgCl2, 10 glucose, and 5.0 HEPES (pH = 7.4 at 20°C). Confluent monolayers of A549 cells grown on permeable filters were washed six times with HPBR or Na+-free HPBR and then incubated in the same solution (±1 µM NBTI) for 30 min. Uptake was initiated by adding 10 µM 14C-labeled adenosine or uridine (0.5 µCi/ml, Amersham Pharmacia Biotech) in HPBR or Na+-free HPBR (±1 µM NBTI) to either the apical or the basolateral compartment. Incubations with adenosine also included 1 µM deoxycoformycin to inhibit adenosine deaminase activity. Uptake was terminated after 30 s to 3 min by 10 rapid washes of the cell culture inserts in an ice-cold "stop" solution containing (in mM) 100 MgCl2 and 10 Tris · HCl (pH = 7.4 at 0°C) (32). The monolayers were dissolved in 0.2 ml 5% (wt/vol) SDS and counted for radioactivity using a Beckman LS 6000IC liquid scintillation counter (Irvine, CA). Nonmediated (passive) uptake was determined in the presence of 1 µM NBTI and excess (5 mM) unlabeled uridine. The protein content of representative monolayers was measured using the Bio-Rad protein standard assay procedure. The flux values shown are means ± SE of n = 5 inserts. Each experiment was repeated at least three times on different batches of cells.

Drugs. Adenosine and deoxycoformycin were prepared in H2O as 10 mM and 1 mM stock solutions, respectively. NBTI was prepared as a 3 mM stock solution in methanol, clotrimazole as a 30 mM stock solution in ethanol, and amiloride as a 10 mM stock solution in H2O. All the above drugs were obtained from Sigma. 9-Chloro-2-(2-furyl)[1,2,4]triazolo[1,5-c]quinazolin-5-amine (CGS-15943) was prepared as a 2 mM stock solution in DMSO, 1-3-dipropyl-8-cyclopentylxanthine (DPCPX) was prepared as a 10 µM stock solution in 0.1 N NaOH, and 3,7-dimethyl-1-propargylxanthine (DMPX) was prepared as a 5 mM stock solution in H2O; all three were purchased from RBI (Natick, MA). Finally, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS; Molecular Probes, Eugene, OR) was prepared as a 5 mM stock solution in H2O, 1-ethyl-2-benzimidazalinone (1-EBIO; Aldrich, Milwaukee, WI) as a 600 mM stock solution in ethanol, and 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone (XE-991, a generous gift from Dr. B. S. Brown, DuPont, Wilmington, DE) as a 10 mM stock solution in 0.1 N HCl.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effect of exogenous and autocrine adenosine on whole cell current in A549 cells. Figure 1A shows typical recordings of whole cell current in A549 cells obtained in nonsymmetrical cationic solutions (pipette 135 mM KCl, bath 135 mM NaCl). Addition of adenosine (100 µM) to the bath solution significantly activated whole cell current (n = 8, P < 0.01). The effect of autocrine adenosine on whole cell current was studied with NBTI, an inhibitor of ENTs. We reasoned that if the uptake of extracellularly produced adenosine were inhibited, its concentration would increase, leading to activation of adenosine receptors. Figure 1B shows that the addition of NBTI (10 µM) to the bath solution had an effect on the whole cell current that was similar to that caused by the addition of exogenous adenosine (n = 15, P < 0.01). Similar experiments performed with NBTI at a concentration that specifically inhibits hENT1 but not hENT2 (1 µM) showed that there was no significant difference (P > 0.05, n = 6) in whole cell current activation by these two concentrations of inhibitor (data not shown). These results suggested that hENT1 may mediate the majority of nucleoside transport in A549 cells.

The observation that NBTI had no effect on whole cell current in the presence of exogenous adenosine suggests a common mechanism of current activation by action on adenosine receptors (Fig. 2). This conclusion was further supported by experiments showing that addition of the nonselective adenosine receptor antagonist CGS-15943 (1 µM) reversed activation of the whole cell current by NBTI (Fig. 3). Interestingly, CGS-15943 alone had no effect on the basal whole cell current (P > 0.05, n = 6; data not shown).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 2.   Adenosine and NBTI, acting in combination, display no additive effects on whole cell current, suggesting a common pathway of activation. A: representative traces showing no further activation of whole cell current when NBTI (10 µM) is added to cells treated with adenosine (100 µM, n = 3). B: summary of experiments done with adenosine in combination with NBTI. All values are means ± SE of chord conductance density. *P < 0.05.



View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   CGS-15943 inhibits NBTI-stimulated whole cell current. A: representative traces showing inhibition of 10 µM NBTI-stimulated whole cell current with 1 µM CGS-15943 (n = 6). B: summary of experiments done with NBTI followed by CGS-15943. All values are means ± SE of chord conductance density. *P < 0.05.

Figure 4 shows the effects of adenosine receptor antagonists on the whole cell current. DPCPX, a specific antagonist of A1 receptors, reversed the effect of adenosine, indicating that these receptors are involved in current activation. In contrast, A2A and A2B receptors appeared not to be involved in this process, because their antagonist, DMPX, had no effect on the current activated by adenosine (Fig. 4, B and D).


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 4.   1-3-Dipropyl-8-cyclopentylxanthine (DPCPX), but not 3,7-dimethyl-1-propargylxanthine (DMPX), inhibits adenosine-stimulated current. A: representative traces showing inhibition of 100 µM adenosine-stimulated whole cell current with 10 nM DPCPX (n = 6). B: representative traces showing that 10 µM DMPX does not inhibit adenosine-stimulated whole cell current (n = 6). C: summary of experiments performed with adenosine followed by DPCPX. D: summary of experiments performed with adenosine followed by DMPX. All values in C and D are means ± SE of chord conductance density. *P < 0.05.

Identification of channel types activated by adenosine. To determine the channel types involved in the response to adenosine, ion replacement and pharmacological studies were performed. Replacement of K+ in the pipette and bath solutions by Cs+ reduced basal conductance by 60%, indicating that K+ channels contribute to basal whole cell current (n = 3, P < 0.05). Under these conditions, addition of adenosine to the bath solution had no effect on the whole cell current, indicating that K+ channels are the major targets for adenosine action (n = 3, P > 0.05).

Epithelial cells possess two distinct classes of K+ channels regulated by cAMP- and Ca2+-mediated agonists, respectively. Therefore, we used selective modulators of these channel families to characterize their contribution to baseline and adenosine-stimulated current. A specific inhibitor of cAMP-dependent K+ channels, XE-991 (10 µM), appeared to affect neither basal whole cell current nor the subsequent response to 100 µM adenosine, suggesting that these channels do not contribute to the cell membrane conductance (n = 4, P > 0.05, paired Student's t-test). In contrast, an opener of IK channels, 1-EBIO (600 µM), increased the mean cell membrane conductance from 75 ± 5 to 468 ± 35 pS/pF and caused a shift in the reversal potential from -14 ± 3 to -68 ± 2 mV, indicating that these channels make a major contribution to the membrane conductance (n = 4, P < 0.0001). This result was further supported by the use of clotrimazole, a selective inhibitor of IK channels (Fig. 5). Clotrimazole (10 µM) inhibited basal whole cell current (P < 0.05, n = 8) and abolished the subsequent response to adenosine, indicating that IK channels were a likely target for adenosine action.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 5.   Clotrimazole inhibits whole cell current and the subsequent response to adenosine. A: representative traces showing clotrimazole (10 µM) inhibition of whole cell current (n = 8) and subsequent lack of response to 100 µM adenosine (n = 3). B: summary of experiments showing the effect of clotrimazole alone and in combination with adenosine. Values are means ± SE of chord conductance density. *P < 0.05.

The effect of adenosine on the activity of Na+ and Cl- channels was evaluated using amiloride and DIDS, respectively. Amiloride (10 µM), a specific blocker of epithelial Na+ channels, appeared to affect neither basal whole cell current nor the subsequent response to 100 µM adenosine (Fig. 6). In contrast, addition of 50 µM DIDS to the bath solution reduced the whole cell current, indicating that DIDS-sensitive Cl- channels make a contribution to the basal current (Fig. 7). However, adenosine in the presence of DIDS significantly increased the current, indicating that other channels were activated by adenosine. In summary, these results have demonstrated that stimulation of A1 receptors in A549 cells activates K+ transport, likely through IK channels.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   Amiloride affects neither basal whole cell current nor the subsequent response to adenosine. A: representative traces showing no effect of amiloride (10 µM, n = 6) on whole cell current and no subsequent alteration of response to 100 µM adenosine (n = 4). B: summary of experiments showing the effect of amiloride alone and in combination with adenosine on cell membrane chord conductance density. Values are means ± SE. *P < 0.05.



View larger version (25K):
[in this window]
[in a new window]
 
Fig. 7.   4,4'-Diisothiocyanostilbene-2,2'- disulfonic acid (DIDS) inhibits basal whole cell current but does not prevent the subsequent response to adenosine. A: representative traces showing DIDS (50 µM) inhibition of whole cell current (n = 12) and subsequent response to 100 µM adenosine (n = 12). B: summary of experiments showing the effect of DIDS alone compared with baseline (*P < 0.05) and DIDS in combination with adenosine compared with DIDS alone (**P < 0.05). Values are means ± SE of chord conductance density.

Identification of adenosine receptors, nucleoside transporters, and IK channels using RT-PCR. The regulatory actions of adenosine are mediated via four subtypes of G protein-coupled receptors distinguished as A1, A2A, A2B, and A3. Gene expression of these receptors was investigated with RT-PCR. As shown in Fig. 8A, A549 cells express mRNA for A1, A2A, and A2B but not A3 receptors. Interestingly, studies with selective adenosine receptor antagonists indicate that only the A1 receptor is involved in the regulation of whole cell current.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 8.   Expression of adenosine receptors, Ca2+-dependent intermediate-conductance K+ (IK) channels, and nucleoside transporters, characterized by RT-PCR. A: A549 cells express transcripts for A1, A2A, and A2B but not A3 receptors. B: A549 cells express IK-1 channel mRNA. A representative positive control, using primers specific for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, is also included. C: A549 cells express transcripts for both human (h) equilibrative nucleoside transporter (ENT)1 and hENT2 but not for concentrative nucleoside transporters hCNT1, hCNT2, and hCNT3. Arrows indicate corresponding DNA marker band sizes for reference. bp, Base pairs.

Electrophysiological studies indicated that IK channels function in A549 cells and are involved in the response to adenosine. Our RT-PCR data confirm the presence of mRNA for the IK-1 protein in A549 cells (Fig. 8B).

Figure 8C shows RT-PCR amplification of nucleoside transporter transcripts in A549 cells. The cells contained mRNA for both ENTs (hENT1 and hENT2) but lacked transcripts for CNTs (hCNT1, hCNT2, and hCNT3).

All PCR products were sequenced and found to be identical to corresponding GenBank sequences (accession numbers given in Table 2). Control amplifications in the absence of added A549 cDNA were negative for all successfully identified adenosine receptors (A1, A2A, and A2B), IK channels (IK-1), and nucleoside transporters (hENT1 and hENT2), whereas control amplifications done with GAPDH primers were always positive.

Functional studies of nucleoside transport by A549 cells. Apical and basolateral uptake of adenosine was measured as a function of time at room temperature and, as shown in Fig. 9, was linear for 3 min (apical > basolateral). Subsequent initial rate measurements to determine the basolateral and apical pathways for adenosine and uridine transport were carried out using a 2-min incubation and are shown in Fig. 10. Apical transport of adenosine was not significantly reduced by removal of extracellular Na+ but was substantially inhibited by 1 µM NBTI, a concentration sufficient to block all hENT1-mediated transport activity (Fig. 10A). NBTI-insensitive adenosine uptake was reduced further in the presence of excess unlabeled uridine. Because adenosine and uridine are both transported by hENT1 and hENT2, this result identifies additional hENT2-mediated and passive components of adenosine uptake. At the concentration of adenosine tested (10 µM), the ratio of the contribution of hENT1 (NBTI sensitive) to that of hENT2 (NBTI insensitive), corrected for passive uptake, was 9:1. Basolateral adenosine transport (Fig. 10B) as well as apical and basolateral transport of uridine (Fig. 10, C and D), a universal ENT/CNT permeant, showed similar characteristics (hENT1-to-hENT2 flux ratios 12:1, 5:1, and 4:1, respectively). These results were consistent with the electrophysiological data, which indicated that the majority of nucleoside transport that effects whole cell current is mediated by hENT1.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 9.   Time course of adenosine uptake across the apical and basolateral membranes of A549 cells. Uptake of 10 µM adenosine (pmol/mg protein) is greater across the apical membrane than the basolateral membrane, and it is linear across both membranes for the first 3 min. Data are means ± SE.



View larger version (25K):
[in this window]
[in a new window]
 
Fig. 10.   Functional characterization of nucleoside uptake in A549 cells. Initial rates of 10 µM adenosine (A, B) and uridine (C, D) uptake (pmol · mg protein-1 · min-1) across the apical (A, C) and basolateral (B, D) membranes were measured over a 2-min time course. In all experiments, nucleoside uptake was not significantly effected by the removal of Na+, indicating an absence of concentrative Na+-nucleoside cotransport. Adenosine and uridine uptake across both apical and basolateral membranes was sensitive to inhibition by 1 µM NBTI. However, a small component of nucleoside uptake was not inhibited by NBTI but was sensitive to inhibition by excess unlabeled uridine (5 mM), indicating a minor contribution of NBTI-insensitive nucleoside transport to total nucleoside transport. The remaining nucleoside uptake was via passive (non-transporter-mediated) mechanisms. Similar patterns were observed for adenosine and uridine uptake, indicating broad permeant selectivity for both NBTI-sensitive and NBTI-insensitive mediated transport in A549 cells.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Extracellular adenosine was shown previously to modulate the function of both cation (3, 6, 29, 39) and anion channels (5, 6, 10, 26, 33, 39) in several epithelia. There are also reports suggesting that the presence of nucleoside transporters in epithelial cells may regulate these effects by controlling the effective concentration of adenosine in the vicinity of its receptors (28, 32). The results presented in this paper confirm and extend these observations by identifying and characterizing the ion channels, adenosine receptors, and nucleoside transporters involved in the regulation of whole cell current in A549 cells.

In the lung, most of the extracellular adenosine is derived from cleavage of the nucleotide AMP by the enzyme 5'-nucleotidase, which is located on the outer surface of the cell plasma membrane (35). AMP, in turn, may be generated from epithelium-derived extracellular ATP and other adenosine nucleotides, including cAMP. Because ATP is present at millimolar concentrations in the cytoplasm, it is possible that release of ATP from injured airway cells contributes to the increased concentration of adenosine found in the airway surface liquid of asthmatic patients. In addition, it has been suggested that cells may secrete ATP, by Ca2+-dependent vesicular exocytosis or through ATP transporters whose identity is still controversial (22). Intracellular levels of adenosine are normally kept low mainly by its conversion to AMP by the enzyme adenosine kinase, which creates an inwardly directed gradient for adenosine entry into the cell. However, the possibility of direct adenosine release from the airway epithelium cannot be excluded, particularly under conditions of stress.

The results presented in this study show that the application of NBTI, a selective inhibitor of hENT1-mediated adenosine transport, had effects on whole cell current similar to those of the application of exogenous adenosine. Furthermore, the effect of NBTI was not additive with that of adenosine and was inhibitable by the adenosine receptor antagonist CGS-15943, indicating that the effect of NBTI is mediated through the activation of adenosine receptors. Therefore, adenosine transporters could regulate epithelial electrolyte secretion by controlling adenosine concentration in the vicinity of its receptors.

It is important to note that CGS-15943 alone had no effect on the baseline current, indicating that endogenous adenosine does not affect the baseline whole cell current. However, several observations suggest that the effect of autocrine adenosine in vivo may be different from that in vitro. First, epithelial cells are normally covered by a thin (~10 µm) layer of airway surface liquid in vivo, whereas cells in our experiments were covered by a ~1-cm-thick layer of bath solution. Second, in vivo, the whole epithelial monolayer contributes to adenosine generation, in contrast to a single cell in patch-clamp studies. Third, other cell types (e.g., mast cells) in the vicinity of the epithelium may contribute to extracellular adenosine concentration in vivo.

The regulatory actions of adenosine are mediated via four subtypes of G protein-coupled receptors, distinguished as A1, A2A, A2B, and A3 (17, 25). Activation of each of these receptors has been linked with the regulation of ion transport in epithelial tissues (3, 4, 26, 39). The results of RT-PCR experiments have shown that A549 cells express A1, A2A, and A2B but not A3 receptors. However, functional studies with specific adenosine receptor antagonists indicate that only the A1 receptor is involved in the regulation of whole cell current by adenosine. Because A1 receptors are linked to Gi1/2/3 proteins and their activation increases inositol 1,4,5-trisphosphate generation and intracellular Ca2+ concentration (17), it is likely that adenosine stimulates whole cell current by activation of Ca2+-dependent ion channels.

Adenosine receptor activation has been shown to activate CFTR Cl- channels (11), non-CFTR Cl- channels (5, 33), amiloride-sensitive Na+ channels (3, 29), and Ca2+-dependent K+ channels (39). Because A549 cells do not express CFTR (16), they constitute a convenient model for the study of the regulation of non-CFTR anion channels. DIDS reduced whole cell current in A549 cells, indicating significant contribution of non-CFTR anion channels to the basal whole cell current. Interestingly, subsequent application of adenosine activated whole cell current, indicating that DIDS-sensitive anion channels may not be targeted by adenosine.

A549 cells were recently shown to contain amiloride-sensitive Na+ channels with molecular and biophysical properties similar to those of alveolar type II cells (27). However, the data from the present study showed whole cell current activation in the presence of amiloride, suggesting that amiloride-sensitive Na+ channels are not affected by adenosine. Similar to other examples of tissue-specific regulation of Na+ channels (for review, see Ref. 31), this result is clearly different from the effect of adenosine on amiloride-sensitive Na+ channels in the kidney (29) and intestine (3), in which adenosine has been shown to be a potent regulator of their function.

Ion replacement studies demonstrated that K+ ions make a major contribution to the basal whole cell current in A549 cells. Studies from several laboratories have shown that Ca2+- and cAMP-mediated agonists regulate IK and KCNQ channels, respectively. IK channels, which are apparently absent in excitable tissues, are predominantly expressed in peripheral tissues including endothelia, epithelia, and the hematopoietic system (23, 24). These channels are thought to play a crucial role in the regulation of Cl- and HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion in human airway epithelial cells (13). Activation of the basolateral cAMP-dependent K+ channel KvLQT1 (KCNQ1), in parallel with the apically located CFTR, has been shown to play an important role in maintaining cAMP-dependent Cl- secretion in human airways (30). In this study we found that XE-991, a specific inhibitor of cAMP-dependent K+ channels (40), had no effect on basal whole cell current or the subsequent response to 100 µM adenosine, suggesting that these channels do not contribute to the cell membrane conductance. In contrast, studies with an opener (1-EBIO) and a blocker (clotrimazole) of IK channels showed that these channels are a major contributor to current. Similarly, the fact that clotrimazole abolished the current response to adenosine indicated that IK channels were a target for adenosine action.

Epithelial nucleoside transport has been most extensively studied in intestine, kidney, liver, and choroid plexus (1, 7, 46). Enterocytes of the small intestine, for example, contain transcripts for all five of the CNT and ENT isoforms (21, 36, 37, 44, 45) and express CNT1/2 functional activity in their apical membrane and ENT1 and/or ENT2 functional activity at the basolateral membrane (reviewed in Ref. 46). Cultured T84 cells, a model of intestinal crypt cells, express basolaterally restricted ENT1/2 functional activity and nucleoside uptake across the apical membrane having the characteristics of passive diffusion (32, 42). Similar properties have been described for the colonic epithelial cell line Caco-2 (42), although an earlier study found these cells to express CNT3-type transport activity at the apical surface (2). Immunocytochemical analyses have demonstrated the presence of CNT1 protein in the apical membrane of rat small intestine but not at the basolateral membrane, and a similar apical localization was identified for kidney proximal tubule (20). In rat liver parenchymal cells, CNT1 was abundant in bile canalicular membranes but largely excluded from sinusoidal membranes (20), which, instead, are enriched in CNT2 immunoreactivity (15). Choroid plexus expresses CNT3-type functional activity (43). Much less is known about nucleoside transport in other epithelia, although pharmacological and RT-PCR studies suggest the presence of CNT2 but not CNT1 in rat epididymal epithelium (9).

In the present study, we have used complementary molecular and functional approaches to investigate the nucleoside transport capabilities of A549 cells. In the first series of experiments, RT-PCR was used in conjunction with isoform-specific oligonucleotide primers to test for the presence of hCNT1, hCNT2, hCNT3, hENT1, and hENT2 mRNA. In the second series, transport studies were used to confirm the identity of the expressed nucleoside transporters and to investigate their vectorial distribution (apical vs. basolateral membrane). Our results show that A549 cells lack transcripts for hCNT1, hCNT2, and hCNT3. Functionally, we also failed to detect any Na+-dependent adenosine or uridine transport activity. Thus A549 cells represent another example of an epithelial cell line lacking Na+-dependent mechanisms of nucleoside transport. Instead, RT-PCR analyses identified transcripts for hENT1 and hENT2. Both transport activities were detected in apical as well as basolateral membranes (hENT1 > hENT2). Although hENT1 and hENT2 both transport adenosine and uridine and are broadly selective for other purine and pyrimidine nucleosides, the two transporters are not functionally equivalent. For example, hENT1 has generally higher apparent substrate affinities, whereas hENT2 is also capable of interacting with nucleobases (12, 18, 19). The two transporters may therefore fulfill complementary but distinct physiological functions.

In summary, the results of this study show that both adenosine receptors and transporters control adenosine effects on K+ channel function in A549 cells. Extracellularly generated adenosine is either transported via ENT1 (or, to a lesser extent, ENT2) into the cell or can activate adenosine receptors expressed on the cell surface. Inhibition of adenosine transport leads to an increase in adenosine concentration in the extracellular space and activation of adenosine receptors. Nucleoside transport may therefore represent an endogenous regulatory mechanism for adenosine-dependent control of ion secretion in human airway epithelial cells. A better understanding of this system could lead to the development of a novel therapeutic strategy in asthma and other respiratory disorders characterized by altered composition and quantity of airway surface liquid.


    ACKNOWLEDGEMENTS

This work was supported by the Alberta Lung Association, the Canadian Institutes of Health Research, the Canadian Cystic Fibrosis Foundation, the National Cancer Institute of Canada (with funds from the Canadian Cancer Society), the Alberta Cancer Board, the Wellcome Trust, and the Medical Research Council of the United Kingdom.


    FOOTNOTES

Address for reprint requests and other correspondence: M. Duszyk, Dept. of Physiology, Univ. of Alberta, 7-46 Medical Sciences Bldg., Edmonton, AB, Canada T6G 2H7 (E-mail: marek.duszyk{at}ualberta.ca).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 8 May 2001; accepted in final form 17 August 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Baldwin, SA, Mackey JR, Cass CE, and Young JD. Nucleoside transporters: molecular biology and implications for therapeutical development. Mol Med Today 5: 216-224, 1999[ISI][Medline].

2.   Belt, JA, Marina NM, Phelps DA, and Crawford CR. Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul 33: 235-252, 1993[ISI][Medline].

3.   Bouritius, H, and Groot JA. Apical adenosine activates an amiloride-sensitive conductance in human intestinal cell line HT29cl19A. Am J Physiol Cell Physiol 272: C931-C936, 1997[Abstract/Free Full Text].

4.   Carré, DA, Mitchell CH, Peterson-Yantorno K, Coca-Prados M, and Civan MM. Similarity of A3 adenosine and swelling-activated Cl- channels in nonpigmented ciliary epithelial cells. Am J Physiol Cell Physiol 279: C440-C451, 2000[Abstract/Free Full Text].

5.   Carré, DA, Mitchell CH, Peterson-Yantorno K, Coca-Prados M, and Civan MM. Adenosine stimulates Cl- channels of nonpigmented ciliary epithelial cells. Am J Physiol Cell Physiol 273: C1354-C1361, 1997[Abstract/Free Full Text].

6.   Casavola, V, Guerra L, Reshkin SJ, Jacobson KA, Verrey F, and Murer H. Effect of adenosine on Na+ and Cl- currents in A6 monolayers. Receptor localization and messenger involvement. J Membr Biol 151: 237-245, 1996[ISI][Medline].

7.   Cass, CE. Nucleoside transport. In: Drug Transport in Antimicrobial and Anticancer Chemotherapy, edited by Georgopapadakou NH.. New York: Dekker, 1995, p. 404-451.

8.   Cass, CE, Young JD, Baldwin SA, Cabrita MA, Graham KA, Griffiths M, Jennings LL, Mackey JR, Ng AM, Ritzel MW, Vickers MF, and Yao SY. Nucleoside transporters of mammalian cells. Pharm Biotechnol 12: 313-352, 1999[Medline].

9.   Chan, TC, Boon GD, Shaffer L, Redmond R, and Pennington KL. Permeation and metabolism of anti-HIV and endogenous nucleosides in human immune effector cells. Biochem Pharmacol 46: 273-278, 1993[ISI][Medline].

10.   Chao, AC, Zifferblatt JB, Wagner JA, Dong YJ, Gruenert DC, and Gardner P. Stimulation of chloride secretion by P1 purinoceptor agonists in cystic fibrosis phenotype airway epithelial cell line CFPEo-. Br J Pharmacol 112: 169-175, 1994[Abstract].

11.   Clancy, JP, Ruiz FE, and Sorscher EJ. Adenosine and its nucleotides activate wild-type and R117H CFTR through an A2B receptor-coupled pathway. Am J Physiol Cell Physiol 276: C361-C369, 1999[Abstract/Free Full Text].

12.   Crawford, CR, Patel DH, Naeve C, and Belt JA. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J Biol Chem 273: 5288-5293, 1998[Abstract/Free Full Text].

13.   Devor, DC, Singh AK, Lambert LC, DeLuca A, Frizzell RA, and Bridges RJ. Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. J Gen Physiol 113: 743-760, 1999[Abstract/Free Full Text].

14.   Driver, AG, Kukoly CA, Ali S, and Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148: 91-97, 1993[ISI][Medline].

15.   Felipe, A, Valdes R, Santo B, Lloberas J, Casado J, and Pastor-Anglada M. Na+-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells. Biochem J 330: 997-1001, 1998[ISI][Medline].

16.   Finkbeiner, WE, Carrier SD, and Teresi CE. Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas. Am J Respir Cell Mol Biol 9: 547-556, 1993[ISI][Medline].

17.   Fredholm, BB, Arslan G, Halldner L, Kull B, Schulte G, and Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 362: 364-374, 2000[ISI][Medline].

18.   Griffiths, M, Beaumont N, Yao SY, Sundaram M, Boumah CE, Davies A, Kwong FY, Coe I, Cass CE, Young JD, and Baldwin SA. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 3: 89-93, 1997[ISI][Medline].

19.   Griffiths, M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD, and Baldwin SA. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 328: 739-743, 1997[ISI][Medline].

20.   Hamilton, SR, Yao SY, Ingram JC, Hadden DA, Ritzel MW, Gallagher MP, Henderson PJ, Cass CE, Young JD, and Baldwin SA. Subcellular distribution and membrane topology of the mammalian concentrative Na+-nucleoside cotransporter rCNT1. J Biol Chem 276: 27981-27988, 2001[Abstract/Free Full Text].

21.   Huang, QQ, Yao SY, Ritzel MW, Paterson AR, Cass CE, and Young JD. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J Biol Chem 269: 17757-17760, 1994[Abstract/Free Full Text].

22.   Illes, P, Klotz KN, and Lohse MJ. Signaling by extracellular nucleotides and nucleosides. Naunyn Schmiedebergs Arch Pharmacol 362: 295-298, 2000[ISI][Medline].

23.   Ishii, TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, and Maylie J. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 94: 11651-11656, 1997[Abstract/Free Full Text].

24.   Jensen, BS, Strobaek D, Christophersen P, Jorgensen TD, Hansen C, Silahtaroglu A, Olesen SP, and Ahring PK. Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel. Am J Physiol Cell Physiol 275: C848-C856, 1998[Abstract].

25.   Klotz, KN. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362: 382-391, 2000[ISI][Medline].

26.   Lazarowski, ER, Mason SJ, Clarke L, Harden TK, and Boucher RC. Adenosine receptors on human airway epithelia and their relationship to chloride secretion. Br J Pharmacol 106: 774-782, 1992[Abstract].

27.   Lazrak, A, Samanta A, and Matalon S. Biophysical properties and molecular characterization of amiloride-sensitive sodium channels in A549 cells. Am J Physiol Lung Cell Mol Physiol 278: L848-L857, 2000[Abstract/Free Full Text].

28.   Leung, GP, Cheung KH, Tse CM, and Wong PY. Na+ reabsorption in cultured rat epididymal epithelium via the Na+/nucleoside cotransporter. Biol Reprod 64: 764-769, 2001[Abstract/Free Full Text].

29.   Ma, HP, and Ling BN. Luminal adenosine receptors regulate amiloride-sensitive Na+ channels in A6 distal nephron cells. Am J Physiol Renal Fluid Electrolyte Physiol 270: F798-F805, 1996[Abstract/Free Full Text].

30.   Mall, M, Wissner A, Schreiber R, Kuehr J, Seydewitz HH, Brandis M, Greger R, and Kunzelmann K. Role of KVLQT1 in cyclic adenosine monophosphate-mediated Cl- secretion in human airway epithelia. Am J Respir Cell Mol Biol 23: 283-289, 2000[Abstract/Free Full Text].

31.   Matalon, S, and O'Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu Rev Physiol 61: 627-661, 1999[ISI][Medline].

32.   Mun, EC, Tally KJ, and Matthews JB. Characterization and regulation of adenosine transport in T84 intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 274: G261-G269, 1998[Abstract/Free Full Text].

33.   Musante, L, Zegarra-Moran O, Montaldo PG, Ponzoni M, and Galietta LJ. Autocrine regulation of volume-sensitive anion channels in airway epithelial cells by adenosine. J Biol Chem 274: 11701-11707, 1999[Abstract/Free Full Text].

34.   Nyce, JW. Insight into adenosine receptor function using antisense and gene-knockout approaches. Trends Pharmacol Sci 20: 79-83, 1999[ISI][Medline].

35.   Phillips, GD, and Holgate ST. Adenosine: its contribution to our understanding of asthma. In: Inflammatory Mechanisms in Asthma, edited by Holgate ST, and Busse WW.. New York: Dekker, 1998, p. 735-753.

36.   Ritzel, MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Ritzel RG, Mowles DA, Carpenter P, Chen XZ, Karpinski E, Hyde RJ, Baldwin SA, Cass CE, and Young JD. Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276: 2914-2927, 2001[Abstract/Free Full Text].

37.   Ritzel, MW, Yao SY, Huang MY, Elliot JF, Cass CE, and Young JD. Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). Am J Physiol Cell Physiol 272: C707-C714, 1997[Abstract/Free Full Text].

38.   Ritzel, MW, Yao SY, Ng AM, Mackey JR, Cass CE, and Young JD. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol Membr Biol 15: 203-211, 2001.

39.   Rugolo, M, Mastrocola T, Whorle C, Rasola A, Gruenert DC, Romeo G, and Galietta LJ. ATP and A1 adenosine receptor agonists mobilize intracellular calcium and activate K+ and Cl- currents in normal and cystic fibrosis airway epithelial cells. J Biol Chem 268: 24779-24784, 1993[Abstract/Free Full Text].

40.   Wang, HS, Brown BS, McKinnon D, and Cohen IS. Molecular basis for differential sensitivity of KCNQ and IKs channels to the cognitive enhancer XE991. Mol Pharmacol 57: 1218-1223, 2000[Abstract/Free Full Text].

41.   Wang, J, Su SF, Dresser MJ, Schaner ME, Washington CB, and Giacomini KM. Na+-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am J Physiol Renal Physiol 273: F1058-F1065, 1997[ISI][Medline].

42.   Ward, JL, and Tse CM. Nucleoside transport in human colonic epithelial cell lines: evidence for two Na+-independent transport systems in T84 and Caco-2 cells. Biochim Biophys Acta 1419: 15-22, 1999[ISI][Medline].

43.   Wu, X, Yuan G, Brett CM, Hui AC, and Giacomini KM. Sodium-dependent nucleoside transport in choroid plexus from rabbit. Evidence for a single transporter for purine and pyrimidine nucleosides. J Biol Chem 267: 8813-8818, 1992[Abstract/Free Full Text].

44.   Yao, SY, Ng AM, Muzyka WR, Griffiths M, Cass CE, Baldwin SA, and Young JD. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem 272: 28423-28430, 1997[Abstract/Free Full Text].

45.   Yao, SY, Ng AM, Ritzel MW, Gati WP, Cass CE, and Young JD. Transport of adenosine by recombinant purine- and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes. Mol Pharmacol 50: 1529-1535, 1996[Abstract].

46.   Young, JD, Cheeseman CI, Mackey JR, Cass CE, and Baldwin SA. Molecular mechanisms of nucleoside and nucleoside drug transport. In: Current Topics in Membranes, edited by Barrett KE, and Donowitz M.. San Diego, CA: Academic, 2000, p. 329-378.


Am J Physiol Cell Physiol 281(6):C1991-C2002
0363-6143/01 $5.00 Copyright © 2001 the American Physiological Society